Wider payer coverage could give GLP-1 revolution a jolt
However, payers aren’t likely to begin putting these GLP-1 treatments on formulary right away, drug policy experts caution.
United States San Diego Inmaculada Hernandez Madrigal Pharma Rezdiffra Novo Saxenda Jeff Levin Scherz
Source: mmm-online.com